SCHEMBL16637612

SCHEMBL16637612

Cc1[c]c(OCCC(C)(C)O)ccn1

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.34
VDR P11473 2/20 0.33
MAPT P10636 1/20 0.31
GSK3B P49841 1/20 0.31
PDE2A O00408 1/20 0.31
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9935470 0.69 ALDH1A1 (0.32) VDR
SCHEMBL4918786 0.69
SCHEMBL13097175 0.69 CYP2D6 (0.44) CYP2D6VDRMAPTGSK3BPDE2A
SCHEMBL27908044 0.67 CYP2D6 (0.46) CYP2D6MAPT
SCHEMBL12003960 0.67 VDR (0.33) CYP2D6VDRPDE2APDE10A
SCHEMBL12004395 0.67 VDR (0.33) CYP2D6VDRPDE2APDE10A
SCHEMBL6255661 0.67 HRH3 (0.49) MAPT
SCHEMBL12004784 0.66 VDR (0.36) CYP2D6VDRPDE2APDE10A
SCHEMBL19783211 0.66 CYP2D6 (0.41) CYP2D6VDRMAPTGSK3BPDE2A
SCHEMBL15782889 0.65 L3MBTL1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145915-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2017-03-29 EP disclosed
EP-3055288-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2016-08-17 EP disclosed
WO-2015176640-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2015-11-26 WO disclosed
WO-2015051725-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2015-04-16 WO disclosed